Friday 6 November 2026 Export ONC’s income statement to Excel — free account

BeOne Medicines Ltd. - Sponsored ADR

BeOne Medicines Ltd. - Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 40.2% from fiscal 2024.

Revenue: +33.8%
EPS: +143.7%
Free cash flow: +33.6%
Total debt: +491.3%

Quarter to September 2026, against a year earlier

406.26 19.01 +4.91%

Follow ONC

Alert me

Market cap: $40.4B
P/E: 68.9×
Fwd P/E: 48.8×
Dividend yield: —
F-score: 7/9
Altman Z: 5.25
Beneish M: −2.73
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26 From the 10-Q filed 5 Nov	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	62.02	48.30	63.86	116.40	+8 more quarters Free account
P/S ratio Full definition →	6.18	5.19	5.74	6.20
P/FCF ratio Full definition →	28.57	24.27	30.10	35.95
P/Operating CF Full definition →	80.26	68.70	163.66	79.39
P/B ratio Full definition →	7.02	6.15	6.92	7.60
Price to Tangible BV Full definition →	7.06	6.22	7.01	7.71
EV/Sales Full definition →	5.48	4.55	5.13	5.59
EV/EBITDA Full definition →	26.67	25.89	35.23	50.74
EV/Operating CF Full definition →	22.77	18.81	22.92	26.50
EV/FCF Full definition →	25.33	21.30	26.91	32.41
Quick Ratio Full definition →	3.08	2.90	3.16	2.96
Current Ratio Full definition →	3.55	3.41	3.64	3.41
Net Debt/EBITDA Full definition →	(10.33)	(11.53)	(13.16)	(16.22)
Debt/Assets Full definition →	8.36%	9.61%	11.25%	11.75%
Debt/Equity Full definition →	0.14	0.17	0.20	0.22
Asset Turnover Full definition →	0.75	0.79	0.80	0.76
Operating CF/Net income Full definition →	1.32	1.95	0.89	6.28
Capex/Depreciation Full definition →	(0.58)	(0.68)	(0.99)	(1.04)
Interest Coverage Full definition →	—	8.18	7.60	4.28
Research and Development Expense of Revenue Full definition →	34.97%	35.91%	35.76%	41.08%
Selling, General and Administrative Expense of Revenue Full definition →	31.40%	34.79%	36.68%	37.06%
Intangible Assets out of Total Assets Full definition →	0.00	0.01	0.01	0.01
Share Based Compensation of Revenue Full definition →	7.01%	8.06%	8.15%	8.26%
Graham Net Nets Full definition →	0.09	0.10	0.09	0.07
Graham Number Full definition →	0.00	78.46	67.00	48.46
Earnings Yield Full definition →	1.61%	2.07%	1.57%	0.86%
Free Cash Flow Yield Full definition →	3.50%	4.12%	3.32%	2.78%
Revenue per Share Full definition →	0.00	15.28	13.64	13.74
Operating CF per Share Full definition →	0.00	4.15	1.81	3.83
Capex per Share Full definition →	0.00	(0.25)	(0.37)	(0.34)
Free Cash Flow per Share Full definition →	0.00	3.90	1.45	3.48
Cash per Share Full definition →	0.00	45.69	43.18	41.70
Shareholders Equity per Share Full definition →	0.00	46.37	42.90	39.99
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	0.00	46.37	42.90	39.99
Free Cash Flow Full definition →	473.53	435.34	160.55	379.83
Working Capital Full definition →	5,697.32	5,096.62	4,789.77	4,404.76
Capital Expenditures Full definition →	(35.17)	(27.48)	(40.79)	(37.52)
Net Current Asset Value Full definition →	3,875.71	3,214.19	2,808.10	2,406.21
EV/EBIT Full definition →	30.72	30.23	42.94	66.82
Capex to Sales Full definition →	0.02	0.02	0.03	0.03
Price to Operating Income Full definition →	34.64	34.44	48.04	74.10
Other line items
Average Receivables Full definition →	977.91	913.48	827.63	770.68
Average Payables Full definition →	440.28	415.54	394.02	442.02
Average Inventory Full definition →	669.80	617.74	588.13	551.61
Average Assets Full definition →	8,754.26	7,737.00	7,197.57	7,054.74
Average Common Equity Full definition →	4,974.86	4,472.24	4,129.98	3,846.71

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly